NEW!

Viral hepatitis is a global public health concern, with an estimated 325 million individuals worldwide living with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. This learning activity reviews the role of antiviral therapy as the cornerstone of chronic hepatitis B (CHB) and C (CHC) management.

Upon completing this module,participants will have a better understanding of the following aspects:

• Epidemiology and burden of disease

• Clinical manifestations and diagnosis of viral hepatitis

• Antiviral therapy

• Screening for hepatocellular carcinoma (HCC)

CPD Reviewer:

Professor Dr Lee Yeong Yeh

Consultant Gastroenterologist and Hepatologist

Universiti Sains Malaysia

NOTE :

Please read thoroughly & understand the module before attempting the assessment questions.

Terms & Conditions:

■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.

■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points.

The modules/articles are best viewed with:

Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards compliant browsermay be required to view the modules.

Sponsored by: